These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 8732288

  • 1. Possible role of nitric oxide in the development of L-2-chloropropionic acid-induced cerebellar granule cell necrosis.
    Widdowson PS, Gyte A, Simpson MG, Farnworth M, Dunn D, Moore RB, Wyatt I, Lock EA.
    Br J Pharmacol; 1996 Apr; 117(8):1761-7. PubMed ID: 8732288
    [Abstract] [Full Text] [Related]

  • 2. Evidence for mediation of L-2-chloropropionic acid-induced delayed neuronal cell death by activation of a constitutive nitric oxide synthase.
    Widdowson PS, Farnworth M, Moore RB, Dunn D, Wyatt I.
    Br J Pharmacol; 1996 Sep; 119(2):374-8. PubMed ID: 8886423
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neuroprotection afforded by MK-801 against L-2-chloropropionic acid-induced cerebellar granule cell necrosis in the rat.
    Lock EA, Gyte A, Duffell SJ, Simpson MG, Wyatt I.
    Toxicology; 1997 Nov 21; 123(1-2):41-51. PubMed ID: 9347923
    [Abstract] [Full Text] [Related]

  • 6. The role of glutathione in L-2-chloropropionic acid induced cerebellar granule cell necrosis in the rat.
    Wyatt I, Gyte A, Simpson MG, Widdowson PS, Lock EA.
    Arch Toxicol; 1996 Nov 21; 70(11):724-35. PubMed ID: 8896718
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. L-2-chloropropionic acid-induced cerebellar granule cell necrosis is potentiated by L-type calcium channel antagonists.
    Widdowson PS, Gyte A, Upton R, Smith JC, Pitts M, Moores R, Wyatt I.
    Arch Toxicol; 1997 Nov 21; 71(12):751-5. PubMed ID: 9388008
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results.
    Salter M, Duffy C, Hazelwood R.
    Neuropharmacology; 1995 Mar 21; 34(3):327-34. PubMed ID: 7543191
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.
    Pfeiffer S, Leopold E, Schmidt K, Brunner F, Mayer B.
    Br J Pharmacol; 1996 Jul 21; 118(6):1433-40. PubMed ID: 8832069
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of nitric oxide synthase inhibitors 7-NI, L-NAME, and L-NOARG in staircase test.
    Pokk P, Väli M.
    Arch Med Res; 2002 Jul 21; 33(3):265-8. PubMed ID: 12031632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.